Perkin-Elmer To Introduce New Instrument Based On Breakthrough DNA Analysis Technology

NORWALK, Conn., May 9, 1998 -- The Perkin-Elmer Corporation (NYSE: PKN) announced today that it was nearing the end of development of a breakthrough DNA analysis technology that should enable the generation of sequencing data at an ultra-high throughput level. The Company is designing the 3700 DNA Analyzer to provide the catalyst for a major new genomics initiative. While production shipments are scheduled for the first quarter of calendar year 1999, Perkin-Elmer expects to shortly announce an early access program for customers interested in becoming test sites for the instrument late in calendar year 1998.

As reported in a separate news announcement made today, Perkin-Elmer, genomics pioneer Dr. J. Craig Venter, and The Institute for Genomic Research (TIGR) have signed letters of intent relating to the formation by Perkin-Elmer and Dr. Venter of a new genomics company which will be a beta test site for the instrument. The new company's strategy will be centered on a plan to substantially complete the sequencing of the human genome in three years.

The 3700 DNA Analyzer, to be priced at approximately $300,000, is the first model of a new product category in DNA sequencing and genetic analysis that is designed to enable applications requiring tens of thousands of samples produced weekly. This production-scale instrument will be marketed with the current 377 and 310 instruments as part of the ABI PRISM family of genetic analysis instruments. The 3700 DNA Analyzer, under development at the Applied Biosystems Division of Perkin-Elmer, combines proven capillary electrophoresis hardware and separation polymer chemistry, with new detection technology and automation.

The 3700 DNA Analyzer is designed for customers who require:

  • Ultra-high throughput
  • 24-hour, multi-run unattended automation, including gel-pouring and sample loading
  • Operating costs that meet the requirements of very large projects such as the completion of

Contact: Timothy Sipols
212-696-4455 x 272
Noonan/Russo Communications

Page: 1 2 3

Related biology news :

1. Perkin-Elmer, Dr. J. Craig Venter, And TIGR Announce Formation Of New Genomics Company
2. Introduced marine species get larger in the invaded region
3. Unveiling all of the consequences: Introduced plants may be causing hidden trouble
4. NCAR Scientists, Aircraft, Instruments Head To Indian Ocean For Climate ChangeExperiment; UCAR Directs Operations
5. Fullerene-Based Materials Clear From Tissue, Go To The Bone
6. Plant-Based Fat Inhibits Growth Of Breast-Cancer Cell Line, UB Researchers Show
7. Plant-Based Fat May Reduce Risk Of Prostate Cancer By Altering Testosterone Metabolism, UB Study Shows
8. NASA Exhibit, Experts To Be In Baltimore Focusing On Space Research Improving Earth-Based Health Care
9. Educators Launch Internet Based Workshop On Pollution Prevention
10. UCSF Researchers Identify Key Genes In Bone Healing Process That Could Lead To New, Molecular-Based Treatments
11. Wood-Based Composites Center Established At Virginia Tech

Post Your Comments:

(Date:1/14/2019)... ... January 14, 2019 , ... CellMax ... cancer cells in blood, will present new findings at the ASCO Gastrointestinal Cancer ... colorectal cancer. The results from this study show CellMax Life’s blood test, based ...
(Date:1/10/2019)... (PRWEB) , ... January 09, 2019 , ... Dr. Beanlands ... Heart Institute in Ottawa, Ontario, Canada. He is also Director of its National ... of Medicine, in the Department of Radiology, and in the Department of Cellular and ...
(Date:1/10/2019)... ... 2019 , ... A major goal for pharmaceutical companies has ... significantly more expensive in vivo studies in order to reduce costs and improve ... researchers have begun to adopt 3D cell culture models which have been shown ...
Breaking Biology News(10 mins):
(Date:12/20/2018)... ... December 20, 2018 , ... New Year’s brings reflection ... changes in regulations in the European Union (EU) on the horizon, Jim Kasic, president ... , “The transition to the EU Medical Device Regulation (MDR), digital health, and big ...
(Date:12/18/2018)... ... December 18, 2018 , ... Patients with early stages of breast cancer who ... post-treatment versus whole breast irradiation, a new study suggests. , Patients with early stage ... irradiation after removal of the cancerous tumor because there is a 30 to 40 ...
(Date:12/13/2018)... ... December 13, 2018 , ... Microbial Discovery Group LLC (MDG) ... been part of their strategic plan and an important milestone in increasing their ... opportunities for MDG within the $44 Billion human probiotic market. This plan is ...
(Date:12/5/2018)... (PRWEB) , ... December 04, ... ... an established North American full-service contract research organization (CRO), announced the acquisition ... transaction significantly strengthens ARG’s reach and experience in the management of clinical ...
Breaking Biology Technology:
Cached News: